BIND Therapeutics To Report Fourth Quarter And Year End 2013 Financial Results And Business Developments On March 25, 2014
3/18/2014 6:40:46 AM
BIND Therapeutics, Inc. (NASDAQ: BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called AccurinsTM, today announced it will report fourth quarter and year ended December 31, 2013 financial results on Tuesday, March 25, 2014. BIND’s management team will host a conference call and audio webcast at 8:30 a.m., Eastern Time, on Tuesday, March 25, 2014 to discuss the quarterly results and recent business developments.
Help employers find you! Check out all the jobs and post your resume.
comments powered by